Effects of Renal Denervation vs Sham in Resistant Hypertension After Medication Escalation: Prespecified Analysis at 6 Months of the RADIANCE-HTN TRIO Randomized Clinical Trial

IMPORTANCE: Although early trials of endovascular renal denervation (RDN) for patients with resistant hypertension (RHTN) reported inconsistent results, ultrasound RDN (uRDN) was found to decrease blood pressure (BP) vs sham at 2 months in patients with RHTN taking stable background medications in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Azizi, Michel, Mahfoud, Felix, Weber, Michael A., Sharp, Andrew S. P., Schmieder, Roland E., Lurz, Philipp, Lobo, Melvin D., Fisher, Naomi D. L., Daemen, Joost, Bloch, Michael J., Basile, Jan, Sanghvi, Kintur, Saxena, Manish, Gosse, Philippe, Jenkins, J. Stephen, Levy, Terry, Persu, Alexandre, Kably, Benjamin, Claude, Lisa, Reeve-Stoffer, Helen, McClure, Candace, Kirtane, Ajay J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647563/
https://www.ncbi.nlm.nih.gov/pubmed/36350593
http://dx.doi.org/10.1001/jamacardio.2022.3904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647563/
https://www.ncbi.nlm.nih.gov/pubmed/36350593
http://dx.doi.org/10.1001/jamacardio.2022.3904

Ejemplares similares